Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.50 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 9/20 | 0.49 |
| ▸ | ADRB1 | P08588 | 9/20 | 0.49 |
| ▸ | ADRB3 | P13945 | 9/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | SNCA | P37840 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9797128 | 0.90 | ADRB2 (0.49) | TAS1R3TAS1R1ALDH1A1ADRB2ADRB1 | |
| SCHEMBL11855174 | 0.86 | ALDH1A1 (0.53) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL11855171 | 0.86 | ALDH1A1 (0.53) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL110051 | 0.86 | ALDH1A1 (0.64) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL18966428 | 0.85 | ADRB2 (0.61) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL9814404 | 0.84 | MAPK1 (0.58) | TAS1R3TAS1R1ALDH1A1TSHRADRB2 | |
| SCHEMBL27668352 | 0.84 | ALDH1A1 (0.62) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL27667934 | 0.84 | ALDH1A1 (0.62) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL27668055 | 0.84 | ALDH1A1 (0.62) | ALDH1A1TSHRPLA2G1BATG4BADRB2 | |
| SCHEMBL10204669 | 0.83 | ALDH1A1 (0.46) | TAS1R3TAS1R1ALDH1A1ADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111675783-B | Pattern forming material, composition for pattern formation, pattern forming method, and method for manufacturing semiconductor device | 铠侠股份有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-111675783-A | Pattern forming material, composition for pattern formation, pattern forming method, and method for manufacturing semiconductor device | 东芝存储器株式会社 | 2020-09-18 | — | — | CN | disclosed |
| CN-104812790-B | Organopolysiloxane graft polymers | 花王株式会社 | 2019-04-12 | — | — | CN | disclosed |
| EP-2927253-B1 | ORGANOPOLYSILOXANE GRAFT POLYMER | KAO CORP (JP) | 2018-09-12 | — | — | EP | disclosed |
| US-9351920-B2 | Organopolysiloxane graft polymer | KAO CORPORATION (JP) | 2016-05-31 | — | — | US | disclosed |
| US-20150297498-A1 | ORGANOPOLYSILOXANE GRAFT POLYMER | KAO CORPORATION (JP) | 2015-10-22 | — | — | US | disclosed |
| EP-2927253-A1 | ORGANOPOLYSILOXANE GRAFT POLYMER | Kao Corporation (JP) | 2015-10-07 | — | — | EP | disclosed |
| CN-104812790-A | Organopolysiloxane graft polymer | KAO CORP | 2015-07-29 | — | — | CN | disclosed |
| US-20080003288-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | disclosed |
| EP-0907666-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. Searle & Co. (US) | 1999-04-14 | — | — | EP | disclosed |
| WO-1997049736-A2 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1997049387-A1 | PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS | G.D. SEARLE AND CO. (US) | 1997-12-31 | — | — | WO | disclosed |
| EP-0391212-B1 | Process for preparing bifunctional Z-stilbene compounds, new bifunctional Z-stilbene compounds and their use for preparing polymers | BAYER AG (DE) | 1994-05-25 | — | — | EP | disclosed |
| US-5136013-A | Polyesters | BAYER AKTIENGESELLSCHAFT (DE) | 1992-08-04 | — | — | US | disclosed |
| US-5068300-A | BIFUNCTIONAL STILBENE COMPOUNDS CONTAINING AT LEAST ONE Z-CONFIGURATED STILBENE GROUP, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF POLYMERS | BAYER AKTIENGESELLSCHAFT (DE) | 1991-11-26 | — | — | US | disclosed |
| EP-0211104-B1 | COMPOSITES | Nippon Shiken Dental Co., Ltd. (JP) | 1991-08-21 | — | — | EP | disclosed |
| EP-0391212-A2 | Process for preparing bifunctional Z-stilbene compounds, new bifunctional Z-stilbene compounds and their use for preparing polymers | BAYER AG (DE) | 1990-10-10 | — | — | EP | disclosed |
| US-4705836-A | Polymerization composition containing vinyl benzoic acid or a derivative thereof and a vinyl compound | NIPPON SHIKEN DENTAL CO., LTD. (JP) | 1987-11-10 | — | — | US | disclosed |
| EP-0211104-A2 | Composites | Nippon Shiken Dental Co., Ltd. (JP) | 1987-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150297498-A1 | ORGANOPOLYSILOXANE GRAFT POLYMER | IDUA, PIGS, GMNN | TAS1R3 909/4885TAS1R1 933/4885ALDH1A1 2410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.